Company intelligence / Profile preview

Apteka Pharmasoft

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Apteka Pharmasoft offers a commercial, data-driven, vertically integrated digital platform used by over 160 community pharmacies in East Africa. The system processes approximately 2.9 million transactions annually, providing actionable insights into antimicrobial usage and resistance patterns to support evidence-based interventions against antimicrobial resistance (AMR). The company is expanding regionally and aims to further integrate AI/ML capabilities for predictive analytics and prescription monitoring.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Local healthcare organizations in East Africa (Kenya, Uganda)

Beyond the preview

Go deeper on Apteka Pharmasoft.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apteka Pharmasoft.

Explore the full profile